CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $570,958 | -14.5% | 26,360 | -19.8% | 0.01% | 0.0% |
| Q4 2022 | $667,630 | +39.7% | 32,872 | +76.4% | 0.01% | +50.0% |
| Q3 2022 | $478,000 | -41.4% | 18,631 | -49.8% | 0.00% | -42.9% |
| Q2 2021 | $816,000 | -7.6% | 37,100 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $883,000 | -39.4% | 37,100 | -33.4% | 0.01% | -38.5% |
| Q4 2020 | $1,457,000 | -51.5% | 55,700 | -67.7% | 0.01% | -59.4% |
| Q3 2020 | $3,002,000 | -3.6% | 172,500 | -6.9% | 0.03% | -13.5% |
| Q2 2020 | $3,115,000 | +33.1% | 185,200 | -4.3% | 0.04% | +85.0% |
| Q4 2019 | $2,341,000 | +118.0% | 193,500 | +154.6% | 0.02% | +100.0% |
| Q3 2019 | $1,074,000 | +145.2% | 76,000 | +234.8% | 0.01% | +150.0% |
| Q3 2017 | $438,000 | +63.4% | 22,700 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $268,000 | -46.5% | 22,700 | -50.3% | 0.00% | -25.0% |
| Q1 2017 | $501,000 | – | 45,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,003,723 | $95,164,000 | 6.41% |
| TANAKA CAPITAL MANAGEMENT INC | 65,609 | $780,000 | 3.41% |
| S&T BANK/PA | 588,620 | $6,999,000 | 1.93% |
| Parallel Advisors, LLC | 1,405,895 | $16,716,000 | 1.35% |
| Matarin Capital Management, LLC | 623,915 | $7,418,000 | 1.15% |
| AJ WEALTH STRATEGIES, LLC | 668,020 | $7,943,000 | 1.08% |
| Capital Impact Advisors, LLC | 177,300 | $2,108,000 | 0.88% |
| Alambic Investment Management, L.P. | 29,547 | $351,000 | 0.85% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 332,436 | $3,953,000 | 0.79% |
| Spark Investment Management LLC | 116,400 | $1,383,000 | 0.74% |